115 related articles for article (PubMed ID: 9680920)
21. Evaluation of the relationship between caries indices and salivary secretory IgA, salivary pH, buffering capacity and flow rate in children with Down's syndrome.
Cogulu D; Sabah E; Kutukculer N; Ozkinay F
Arch Oral Biol; 2006 Jan; 51(1):23-8. PubMed ID: 16039983
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
Ingle JN; Foley JF; Mailliard JA; Krook JE; Hartmann LC; Jung SH; Veeder MH; Gesme DH; Hatfield AK; Goldberg RM
Cancer; 1994 May; 73(9):2337-43. PubMed ID: 8168039
[TBL] [Abstract][Full Text] [Related]
23. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
24. Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition.
Del Rio G; Zironi S; Valeriani L; Menozzi R; Bondi M; Bertolini M; Piccinini L; Banzi MC; Federico M
Breast Cancer Res Treat; 2002 Jun; 73(3):267-73. PubMed ID: 12160332
[TBL] [Abstract][Full Text] [Related]
25. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
[TBL] [Abstract][Full Text] [Related]
26. Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer.
Beex LV; Hermus AR; Pieters GF; van Hoesel QG; Nooy MA; Mignolet F
Eur J Cancer; 1992; 28(2-3):686-90. PubMed ID: 1591094
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
[TBL] [Abstract][Full Text] [Related]
28. Increased salivary immunoglobulin A and reduced α-amylase activity in whole saliva from spastic cerebral palsy individuals.
Leite MF; Aznar LC; Ferreira MC; Guaré RO; Santos MT
J Oral Pathol Med; 2013 Jul; 42(6):480-5. PubMed ID: 23398490
[TBL] [Abstract][Full Text] [Related]
29. Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.
Colleoni M; Price KN; Castiglione-Gertsch M; Gelber RD; Coates AS; Goldhirsch A
Lancet; 1999 Jul; 354(9173):130-1. PubMed ID: 10408495
[TBL] [Abstract][Full Text] [Related]
30. Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
de Azambuja E; Ameye L; Diaz M; Vandenbossche S; Aftimos P; Bejarano Hernández S; Shih-Li C; Delhaye F; Focan C; Cornez N; Vindevoghel A; Beauduin M; Lemort M; Paesmans M; Suter T; Piccart-Gebhart M
Eur J Cancer; 2015 Nov; 51(17):2517-24. PubMed ID: 26321502
[TBL] [Abstract][Full Text] [Related]
31. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery.
Faul C; Brufsky A; Gerszten K; Flickinger J; Kunschner A; Jacob H; Vogel V
Eur J Cancer; 2003 Apr; 39(6):763-8. PubMed ID: 12651201
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy-associated myelosuppression in gynecological oncology].
Janni W; Rjosk D; Strobl B; Bergauer F; Linka F; Dimpfl T; Schindlbeck C; Rack B; Kaestner R; Sommer H
Gynakol Geburtshilfliche Rundsch; 2001; 41(3):166-73. PubMed ID: 11904473
[TBL] [Abstract][Full Text] [Related]
33. Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis.
Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
BMC Oral Health; 2017 Jun; 17(1):103. PubMed ID: 28662707
[TBL] [Abstract][Full Text] [Related]
34. Salivary: flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis.
Knaś M; Zalewska A; Waszkiewicz N; Szulimowska J; Dziezcioł J; Sierakowski S; Waszkiel D
J Oral Pathol Med; 2014 Aug; 43(7):521-9. PubMed ID: 25184163
[TBL] [Abstract][Full Text] [Related]
35. Salivary Immunoglobulin A Secretion Rate Is Negatively Associated with Cancer Mortality: The West of Scotland Twenty-07 Study.
Phillips AC; Carroll D; Drayson MT; Der G
PLoS One; 2015; 10(12):e0145083. PubMed ID: 26699127
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
37. Analyses of salivary components in leukemia patients receiving chemotherapy.
Månsson-Rahemtulla B; Techanitiswad T; Rahemtulla F; McMillan TO; Bradley EL; Wahlin YB
Oral Surg Oral Med Oral Pathol; 1992 Jan; 73(1):35-46. PubMed ID: 1376467
[TBL] [Abstract][Full Text] [Related]
38. Levels of Salivary Immunoglobulin A (SIgA) in HIV Infected Children.
Subramaniam P; Kumar K; Girish Babu KL
J Clin Pediatr Dent; 2015; 39(4):377-81. PubMed ID: 26161611
[TBL] [Abstract][Full Text] [Related]
39. Effect of free-living daily physical activity on salivary secretory IgA in elderly.
Shimizu K; Kimura F; Akimoto T; Akama T; Kuno S; Kono I
Med Sci Sports Exerc; 2007 Apr; 39(4):593-8. PubMed ID: 17414795
[TBL] [Abstract][Full Text] [Related]
40. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
Fisher B; Brown AM; Dimitrov NV; Poisson R; Redmond C; Margolese RG; Bowman D; Wolmark N; Wickerham DL; Kardinal CG
J Clin Oncol; 1990 Sep; 8(9):1483-96. PubMed ID: 2202791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
